Gene symbol and protein  | Gene Location  | All allelic disease phenotypes - locus/disease symbols  | 
TARDBPTAR DNA binding protein         | 1p36.2  |  * amyotrophic lateral sclerosis 10 - ALS10 (4.29, 12.63) * Distal myopathy, late-onset -  (4.29, 12.63)
 
  | 
 | Xq28  |  * Barth syndrome - BTHS (10.103, 10.90)
  * Endocardial fibroelastosis-2 - G4.5 (10.103, 10.90)
  * Noncompaction of left ventricular myocardium, isolated - INVM (10.103, 10.90)
  * Cardiomyopathy, X-linked dilated - CMD3A (10.103, 10.90)
 
  | 
TBK1Tank-binding kinase 1         | 12q14.2  |  * Amyotrophic lateral sclerosis and/or frontotemporal dementia - FTDALS4 (12.88)
 
  | 
TBPTATA box binding protein          | 6q27  |  * Spinocerebellar ataxia 17 - SCA17 (13.15)
 
  | 
 | 17q12  | * Dilated cardiomyopathy, 1N -  (2.16, 10.27, 10.51) * Congenital musuclar dystrophy with telethonin defect -  (2.16, 10.27, 10.51)
  * Hypertrophic cardiomyopathy related to TCAP - CMH25 (2.16, 10.27, 10.51)
  * Muscular dystrophy, limb-girdle, type 2G - LGMD2G (2.16, 10.27, 10.51)
   | 
TDP1Tyrosyl-DNA phosphodiesterase 1         | 14q31-q32  |  * spinocerebellar ataxia, autosomal recessive, with axonal neuropathy - SCAN1 (13.94)
 
  | 
TDP2Tyrosyl-DNA phosphodiesterase 2          | 6p22.3  |  * Spinocerebellar ataxia, autosomal recessive 23 - SCAR23 (13.83)
 
  | 
TECPR2Tectonin beta-propeller repeat containing 2         | 14q32  | * Spastic paraplegia 49, autosomal recessive - SPG49 (14.114, 15.49)
  * Neuropathy, hereditary sensory and autonomic, type IX, with developmental delay - HSAN9 (14.114, 15.49)
   | 
TECRLTrans-2,3-Enoyl-CoA Reductase-Like Protein        | 4q13.1  |  * Ventricular tachycardia, catecholaminergic polymorphic, recessive - CPVT3 (10.130)
 
  | 
 | 3q13  |  * Hereditary motor and sensory, neuropathy, proximal, type - HMSNP (14.71, 15.57)
  * Neuropathy, hereditary motor and sensory, Okinawa type - HMSNO (14.71, 15.57)
  * Spastic paraplegia 57, autosomal recessive - SPG57 (14.71, 15.57)
 
  | 
TGFB3Transforming growth factor, beta 3         | 14q24.3  |  * Arrhythmogenic right ventricular dysplasia, familial, 1 - ARVD1 (10.115)
  * Arrhythmogenic right ventricular dysplasia, 1 - TGFB3 (10.115)
 
  | 
 | 20p13  |  * Spinocerebellar ataxia 35 - SCA35 (13.31)
 
  | 
THAP11THAP domain-containing protein 11         | 16q22.1  |  * Spinocerebellar ataxia 51 - SCA51 (13.47)
 
  | 
THG1LtRNA-histidine guanyltransferase 1-like protein         | 5q33.3  |  * Spinocerebellar ataxia, autosomal recessive 28 - SCAR28 (13.88)
 
  | 
THOC2Tho complex, subunit 2         | Xq25  |  * Arthrogryposis multiplex congenita 7, X-linked - AMC7 (17.26)
 
  | 
TIA1Cytotoxic granuleassociated RNA binding protein         | 2p13  |  * Welander distal myopathy - WDM (4.14, 4.15, 12.79)
 
  | 
TIMM22Translocase of inner mitochondrial membrane 22(M)         | 17q13.3  |  * Combined oxidative phosphorylation deficiency 43 - COXPD43 (16.25)
 
  | 
TK2Thymidine kinase 2, mitochondrial(M)         | 16q22-q23  |  * Mitochondrial dna depletion syndrome, myopathic form - MTDPS3 (13.28, 16.9, 16.13)
  * Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 3 - PEOB3 (13.28, 16.9, 16.13)
 
  | 
TMEM126BTransmembrane protein 126B(M)         | 11q14.1  |  * Mitochondrial complex I deficiency, nuclear type 29 - MC1DN29 (16.31)
 
  | 
TMEM168Transmembrane protein 168        | 7q31.1   | * Brugada syndrome - BRGDA (10.186)
   | 
TMEM240Transmembrane protein 240         | 1p36.33  |  * Spinocerebellar ataxia 19 - SCA21 (13.19)
 
  | 
TMEM43Transmembrane protein 43         | 3p25.1  | * luma related muscular dystrophy  -  (1.8, 10.119)
  * arrhythmogenic right ventricular dysplasia, familial, 5 - ARVD5 (1.8, 10.119)
  * Emery-dreifuss muscular dystrophy 7 - EDMD7 (1.8, 10.119)
   | 
TMEM63CTransmembrane protein 63c         | 14q324.3  |  * Spastic paraplegia 87, autosomal recessive - SPG87 (15.76)
 
  | 
TMEM65Transmembrane Protein 65        | 8q24.13  | * Mitochondrial myopathy with severe neurological manifestations -  (16.27)
   | 
TMPOLamina-associated polypeptide 2         | 12q22  |  * Cardiomyopathy, dilated, 1T - CMT1T (10.57)
 
  | 
 | 3p21.3-p14.3  |  * Cardiomyopathy, dilated, 1Z - CMD1Z (10.12, 10.63)
  * Familial hypertrophic cardiomyopathy, 13 - CMH13 (10.12, 10.63)
 
  | 
 | 20q13.12  |  * Congenital myopathy 15 - CMYP15 (3.54)
 
  | 
 | 11p15.5  |  * Arthrogryposis, distal, type 2B - DA2B (17.12)
 
  | 
 | 19q13.4  |  * Cardiomyopathy, dilated, 1FF - CMD1FF (10.6, 10.69, 10.81, 10.96)
  * Cardiomyopathy, familial hypertrophic - CMH7 (10.6, 10.69, 10.81, 10.96)
  * Cardiomyopathy, familial restrictive - RCM (10.6, 10.69, 10.81, 10.96)
 
  | 
 | 19q13.4  |  * Nemaline myopathy 5 - NEM5 (3.7)
 
  | 
TNNT2Troponin T2, cardiac         | 1q32  |  * Cardiomyopathy, familial hypertrophic, 2 - CMH2 (10.2, 10.109, 10.42, 10.98)
  * Left ventricular noncompaction 6  - LVNC6 (10.2, 10.109, 10.42, 10.98)
  * Cardiomyopathy, dilated, 1D - CMD1D (10.2, 10.109, 10.42, 10.98)
 
  | 
TNNT3Troponin T3, skeletal         | 11p15.5  |  * Arthrogryposis, distal, type 2B - DA2B (3.16, 17.13) * Nemalin myopathy with distal arthrogryposis -  (3.16, 17.13)
 
  | 
 | 7q32.1-q32.2  |  * Muscular dystrophy, Limb-Girdle, Type 1F - LGMD1F (1.17, 3.62) * Congenital Myopathy related to TNPO3 -  (1.17, 3.62)
 
  | 
TOMM70Translocase of Outer Mitochondrial Membrane 70        | 3q12.2  | * Neurological impairment -  (13.55)
   | 
TOP3ADNA topoisomerase III         | 17p11.2  |  * Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5 - PEOB5 (16.11)
 
  | 
 | 9q34  |  * Torsion dystonia, early onset - EOTD (17.1)
 
  | 
TOR1AIP1Torsin A interacting protein 1        | 1q25.2  | * LAP1B related muscular dystrophy -  (1.9, 11.41)
  * Limb-Girdle, Muscular dystrophy, type 2Y - LGMD2Y (1.9, 11.41)
  * Myopathy, autosomal recessive, with rigid spine and distal joint contractures - MRRSDC (1.9, 11.41) * Congenital myasthenic syndrome -  (1.9, 11.41)
   | 
TPM1Tropomyosin 1 (alpha)         | 15q22  |  * Cardiomyopathy, dilated, 1Y - CMD1Y (10.3, 10.112, 10.62)
  * Left ventricular noncompaction 9 - LVNC9 (10.3, 10.112, 10.62)
  * Cardiomyopathy, familial hypertrophic, 3 - CMH3 (10.3, 10.112, 10.62)
 
  | 
 | 9p13  |  * Arthrogryposis, distal, type 1A - DA1A (3.6, 3.36, 17.9, 17.15)
  * arthrogryposis, distal, type 2B - DA2B (3.6, 3.36, 17.9, 17.15)
  * Cap myopathy, TPM2-related, included -  (3.6, 3.36, 17.9, 17.15)
  * Nemaline myopathy 4 - NEM4 (3.6, 3.36, 17.9, 17.15)
 
  | 
 | 1q21.2  |  * Nemaline myopathy 1, autosomal dominant - NEM1 (3.3, 3.4)
 
  | 
TPP1Tripeptidyl peptidase I          | 11p15.4  |  * Spinocerebellar ataxia, autosomal recessive 7 - SCAR7 (13.67)
 
  | 
TRAPPC11Trafficking protein particle complex 11         | 4q35.1  |  * Limb-Girdle, Muscular dystrophy, type 2S - LGMD2S (1.35, 2.42) * Congenital muscular dystrophy with fatty liver and infantile-onset cataract caused by TRAPPC11 mutations: broadening of the phenotype - CMD (1.35, 2.42)
 
  | 
TRAPPC2LTrafficking protein particle complex 2-like        | 16q24.3  | * Congenital muscular dystrophy related to TRAPPC2L -  (2.52)
   | 
 | 6q22.31  |  * Cardiac arrhythmia syndrome, with or without skeletal muscle weakness - CPVT5 (10.132)
 
  | 
TRIM2Tripartite motif containing 2         | 4q31.3  |  * Charcot-Marie-Tooth neuropathy Type 2R - CMT2R (14.90)
 
  | 
TRIM32Tripartite motif-containing 32         | 9q33.2  | * Sarcotubular myopathy -  (1.31, 3.42)
  * Muscular dystrophy, limb-girdle, type 2H - LGMD2H (1.31, 3.42)
   | 
TRIM54Tripartite motif-containing 54         | 2p.23.3  | * Cardiac and skeletal aggregate myopathy -  (5.14)
   | 
TRIM63Tripartite motif containing 63, E3 ubiquitin protein ligase         | 1p36.11  | * Cardiac and skeletal aggregate myopathy -  (5.14)
   | 
TRIP4Thyroid hormone receptor interactor 4         | 15q22.31  | * Muscular dystrophy, congenital Davignon-Chauveau type - MDCD (2.48, 12.16)
  * Spinal muscular atrophy with congenital bone fractures 1 - SMABF1 (2.48, 12.16)
   | 
TRPC3Transient receptor potential cation channel subfamily C member 3         | 4q27  |  * Spinocerebellar ataxia 41 - SCA41 (13.36)
 
  | 
TRPV4Transient receptor potential cation channel, subfamily V, member 4          | 12q23-q24  |  * Scapuloperoneal spinal muscular atrophy - SPSMA (12.30, 12.39, 14.50)
  * Neuronopathy, distal hereditary motor, type VIII - HMN8 (12.30, 12.39, 14.50)
  * Spinal muscular atrophy congenital non progressive of lower limbs - SMAL (12.30, 12.39, 14.50)
  * Spinal muscular atrophy, congenital benin, with contractures - SMAL (12.30, 12.39, 14.50)
 
  | 
TSFMTs translation elongation factor, mitochondrial(M)         | 12q14.1  |  * Mitochondrial hypertrophic cardiomyopathy related to TSFM  - COXPD3 (10.32)
 
  | 
TTBK2Tau tubulin kinase 2         | 15q15.2  |  * Spinocerebellar ataxia  11     - SCA11 (13.10)
 
  | 
 | 2q31  |  * Hereditary myopathy with early respiratory failure - HMERF (1.32, 3.24, 3.28, 3.39, 4.4, 5.10, 10.8, 10.44, 12.101)
  * Cardiomyopathy, familial hypertrophic, 9 - CMH9 (1.32, 3.24, 3.28, 3.39, 4.4, 5.10, 10.8, 10.44, 12.101) * Congenital myopathy with fatal cardiomyopathy -  (1.32, 3.24, 3.28, 3.39, 4.4, 5.10, 10.8, 10.44, 12.101)
  * Cardiomyopathy, dilated, 1G - CMD1G (1.32, 3.24, 3.28, 3.39, 4.4, 5.10, 10.8, 10.44, 12.101) * Centronuclear myopathy related to TTN -  (1.32, 3.24, 3.28, 3.39, 4.4, 5.10, 10.8, 10.44, 12.101) * LGMDR10 (Formerly LGMD2J)  -  (1.32, 3.24, 3.28, 3.39, 4.4, 5.10, 10.8, 10.44, 12.101) * Lethal Congenital Contracture Syndrome related to TTN -  (1.32, 3.24, 3.28, 3.39, 4.4, 5.10, 10.8, 10.44, 12.101)
  * Congenital myopathy 5 with cardiomyopathy (formerly Salih myopathy) - CMYP5 (SALMY) (1.32, 3.24, 3.28, 3.39, 4.4, 5.10, 10.8, 10.44, 12.101)
  * Autosomal dominant myopathy with proximal muscle weakness and early respiratory  -  (1.32, 3.24, 3.28, 3.39, 4.4, 5.10, 10.8, 10.44, 12.101)
  * Tibial muscular dystrophy, tardive - TMD (1.32, 3.24, 3.28, 3.39, 4.4, 5.10, 10.8, 10.44, 12.101)
  * Limb girdle muscular dystrophy 2J (autosomal recessive)  - LGMD2J (1.32, 3.24, 3.28, 3.39, 4.4, 5.10, 10.8, 10.44, 12.101)
 
  | 
TTPATocopherol (alpha) transfer protein (ataxia (Friedreich-like) with vitamin E deficiency)         | 8q13.1-q13.3  |  * Ataxia, Friedreich-like, with selective vitamin E deficiency - AVED (13.59)
  * Ataxia with isolated vitamin E deficiency - TTPA (13.59)
 
  | 
TTRTransthyretin (prealbumin, amyloidosis type I)         | 18q12.1  | * Familial amyloid neuropathy -  (17.4)
   | 
 | 2q35  |  * Amyotrophic lateral sclerosis 22 - ALS22 (12.75)
 
  | 
 | 16q24.3  |  * Fibrosis of extraocular muscles, congenital, 3 - CFEOM3 (17.7)
 
  | 
TWNKTwinkle mtDNA helicase         | 10q23.-q24.1  |  * Spinocerebellar ataxia, infantile-onset, with sensory neuropathy             - IOSCA (13.60, 16.3)
  * Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal - PEO3A (13.60, 16.3)
 
  | 
TYMPThymidine phosphorylase         | 22q13.33  |  * Mitochondrial DNA depletion syndrome 1  (MNGIE type)  - MTDPS1 (16.12)
 
  |